MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate, long-read sequencing technology, today announced that its new HiFiViral SARS-CoV-2 solution has successfully sequenced and captured the entire genome of the SARS-CoV-2 Omicron variant lineage. The solution gives researchers around the globe a powerful tool to access complete genomic information on Omicron, […]

ArcticZymes Technologies launches new products and opens new production facility ArcticZymes technologies launches the following products: ArcticZymes R2DTM Ligase – Patent pending ligase with novel specificity enabling the ligation of DNA to both ends of RNA using a DNA splint. The enzyme is an enabling tool for new technology development and is expected to have broad applicability […]

Partnering to build biosynthesis processes and a pharmaceutical production platform Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has invested in GlyTech, Inc., a Kyoto-based company with leading-edge technologies in the synthesis of glycans, which influence cell metabolism and functional changes. The companies will partner with the aim of establishing biosynthesis processes that […]

SAN DIEGO — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of the leading software solutions for visualization, interpretation and reporting of genomic data, today announced that University Hospitals Leuven in Belgium, after previously receiving its accreditation from the Belgian Accreditation Body (BELAC) for using OGM in analysis […]

See more cells, more clearly than ever before. With the largest in-class field of view, Scientifica’s latest addition to our modular portfolio of multiphoton imaging solutions, the VistaScope, is an industry-leading development. The VistaScope will enable researchers to see more cells simultaneously – in fact, twice as many cells – compared to the closest competitor. The monumental […]

Researchers around the world can utilize the synthetic genome to produce virus to test strain-specific diagnostics, monoclonal antibody treatments, small-molecule therapies, or new vaccines against the highly transmissible variant SAN DIEGO — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of a new full-length synthetic genome […]

Cytiva has been awarded a USD 147.6 million contract from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in coordination with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, […]

Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential markets and applications for its pioneering HTG Transcriptome Panel (HTP). Since launching HTP with commercial availability in […]

ArcticZymes Technologies launches new products and opens new production facility ArcticZymes technologies launches the following products: ArcticZymes R2DTM Ligase – Patent pending ligase with novel specificity enabling the ligation of DNA to both ends of RNA using a DNA splint. The enzyme is an enabling tool for new technology development and is expected to have broad applicability […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced William A. Geist has been appointed President, Protein Sciences Segment, effective January 3, 2022.  Mr. Geist succeeds N. David Eansor, who will be retiring from the Company. Mr. Eansor will remain with Bio-Techne through the end of February 2022 to ensure a smooth transition. Mr. Geist has […]